Safety and efficacy of ketoconazole (K) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Contemporary experience and prognostic indicators.
M. A. Eisenberger
No relevant relationships to disclose
P. Huang
No relevant relationships to disclose
V. J. Sinibaldi
No relevant relationships to disclose
M. A. Carducci
No relevant relationships to disclose
S. R. Denmeade
No relevant relationships to disclose
E. S. Antonarakis
No relevant relationships to disclose
J. J. Kim
No relevant relationships to disclose
D. Keizman
No relevant relationships to disclose